0001214659-23-016106.txt : 20231206 0001214659-23-016106.hdr.sgml : 20231206 20231206170536 ACCESSION NUMBER: 0001214659-23-016106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231127 FILED AS OF DATE: 20231206 DATE AS OF CHANGE: 20231206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hamm John M. CENTRAL INDEX KEY: 0001870439 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 231470401 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 marketforms-63729.xml PRIMARY DOCUMENT X0508 4 2023-11-27 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001870439 Hamm John M. 1600 WEST END AVENUE, SUITE 1300 NASHVILLE TN 37203 false true false false Chief Financial Officer 0 Common Stock 2023-11-27 4 F false 352 1.67 D 26448 D John Hamm 2023-12-06